Page last updated: 2024-08-23

tetradecanoylphorbol acetate and epirubicin

tetradecanoylphorbol acetate has been researched along with epirubicin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davey, MW; Davey, RA; Kidman, AD; Marks, DC1
Ala, U; Brusa, D; Calautti, E; Magnuson, MA; Neri, F; Oliviero, S; Provero, P; Riganti, C; Saoncella, S; Tassone, B1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and epirubicin

ArticleYear
Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
    Biochemical pharmacology, 1995, Aug-08, Volume: 50, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Butyrates; Butyric Acid; Cell Differentiation; Cell Survival; Colchicine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia; Phenotype; Rhodamine 123; Rhodamines; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil

1995
Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.
    Cell death and differentiation, 2017, Volume: 24, Issue:4

    Topics: Acetylcysteine; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cellular Senescence; Epirubicin; Glutamic Acid; Hyperplasia; Keratin-14; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Radiation Tolerance; Rapamycin-Insensitive Companion of mTOR Protein; Reactive Oxygen Species; Skin; Tetradecanoylphorbol Acetate; Transcriptome; X-Rays

2017